EDAP TMS S.A Gross Margin 2010-2024 | EDAP
Current and historical gross margin for EDAP TMS S.A (EDAP) over the last 10 years. The current gross profit margin for EDAP TMS S.A as of September 30, 2024 is %.
| EDAP TMS S.A Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $0.07B | $0.03B | 41.18% |
| 2024-06-30 | $0.07B | $0.03B | 40.30% |
| 2024-03-31 | $0.07B | $0.03B | 40.91% |
| 2023-12-31 | $0.07B | $0.03B | 40.91% |
| 2023-09-30 | $0.06B | $0.03B | 40.98% |
| 2023-06-30 | $0.06B | $0.03B | 41.67% |
| 2023-03-31 | $0.06B | $0.03B | 44.07% |
| 2022-12-31 | $0.06B | $0.03B | 43.10% |
| 2022-09-30 | $0.06B | $0.03B | 43.10% |
| 2022-06-30 | $0.06B | $0.02B | 42.11% |
| 2022-03-31 | $0.05B | $0.02B | 40.74% |
| 2021-12-31 | $0.05B | $0.02B | 41.18% |
| 2021-09-30 | $0.05B | $0.02B | 41.51% |
| 2021-06-30 | $0.05B | $0.02B | 43.40% |
| 2021-03-31 | $0.05B | $0.02B | 45.10% |
| 2020-12-31 | $0.05B | $0.02B | 44.68% |
| 2020-09-30 | $0.04B | $0.02B | 45.24% |
| 2020-06-30 | $0.04B | $0.02B | 45.24% |
| 2020-03-31 | $0.05B | $0.02B | 45.65% |
| 2019-12-31 | $0.05B | $0.02B | 48.00% |
| 2019-09-30 | $0.05B | $0.03B | 48.08% |
| 2019-06-30 | $0.05B | $0.02B | 48.00% |
| 2019-03-31 | $0.05B | $0.02B | 45.65% |
| 2018-12-31 | $0.05B | $0.02B | 44.44% |
| 2018-09-30 | $0.04B | $0.02B | 42.86% |
| 2018-06-30 | $0.04B | $0.02B | 41.46% |
| 2018-03-31 | $0.04B | $0.02B | 41.46% |
| 2017-12-31 | $0.04B | $0.02B | 41.03% |
| 2017-09-30 | $0.04B | $0.02B | 43.59% |
| 2017-06-30 | $0.04B | $0.02B | 45.00% |
| 2017-03-31 | $0.04B | $0.02B | 46.15% |
| 2016-12-31 | $0.04B | $0.02B | 47.50% |
| 2016-09-30 | $0.04B | $0.02B | 46.34% |
| 2016-06-30 | $0.04B | $0.02B | 46.15% |
| 2016-03-31 | $0.04B | $0.02B | 46.15% |
| 2015-12-31 | $0.04B | $0.02B | 44.44% |
| 2015-09-30 | $0.03B | $0.01B | 41.94% |
| 2015-06-30 | $0.03B | $0.01B | 42.42% |
| 2015-03-31 | $0.03B | $0.01B | 37.50% |
| 2014-12-31 | $0.04B | $0.01B | 38.89% |
| 2014-09-30 | $0.04B | $0.02B | 41.03% |
| 2014-06-30 | $0.04B | $0.02B | 40.54% |
| 2014-03-31 | $0.04B | $0.02B | 42.86% |
| 2013-12-31 | $0.03B | $0.01B | 40.63% |
| 2013-09-30 | $0.03B | $0.01B | 39.39% |
| 2013-06-30 | $0.03B | $0.01B | 39.39% |
| 2013-03-31 | $0.04B | $0.01B | 40.00% |
| 2012-12-31 | $0.03B | $0.01B | 41.18% |
| 2012-09-30 | $0.03B | $0.01B | 40.63% |
| 2012-06-30 | $0.03B | $0.01B | 41.18% |
| 2012-03-31 | $0.03B | $0.01B | 40.63% |
| 2011-12-31 | $0.03B | $0.01B | 40.63% |
| 2011-09-30 | $0.03B | $0.01B | 39.39% |
| 2011-06-30 | $0.03B | $0.01B | 38.71% |
| 2011-03-31 | $0.03B | $0.01B | 39.39% |
| 2010-12-31 | $0.03B | $0.01B | 37.50% |
| 2010-09-30 | $0.03B | $0.01B | 39.39% |
| 2010-06-30 | $0.03B | $0.01B | 36.36% |
| 2010-03-31 | $0.03B | $0.01B | 38.24% |
| 2009-12-31 | $0.04B | $0.01B | 40.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.081B | $0.065B |
| EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.335B | 24.68 |
| Intuitive Surgical (ISRG) | United States | $191.275B | 100.00 |
| Edwards Lifesciences (EW) | United States | $44.459B | 28.23 |
| Alcon (ALC) | Switzerland | $42.458B | 28.41 |
| IQVIA Holdings (IQV) | United States | $36.298B | 20.00 |
| IDEXX Laboratories (IDXX) | United States | $33.869B | 39.89 |
| DexCom (DXCM) | United States | $31.341B | 47.20 |
| Waters (WAT) | United States | $22.156B | 32.76 |
| STERIS (STE) | Ireland | $20.598B | 23.71 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.820B | 0.00 |
| Hologic (HOLX) | United States | $16.494B | 17.81 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.327B | 13.68 |
| Sysmex ADR (SSMXY) | Japan | $11.738B | 36.81 |
| Globus Medical (GMED) | United States | $11.366B | 28.78 |
| Penumbra (PEN) | United States | $9.225B | 90.36 |
| Masimo (MASI) | United States | $9.011B | 43.60 |
| Glaukos (GKOS) | United States | $8.338B | 0.00 |
| Teleflex (TFX) | United States | $8.233B | 13.13 |
| Integer Holdings (ITGR) | United States | $4.520B | 25.62 |
| PROCEPT BioRobotics (PRCT) | United States | $4.369B | 0.00 |
| Veracyte (VCYT) | United States | $3.191B | 95.77 |
| Inari Medical (NARI) | United States | $3.141B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.539B | 14.65 |
| Tandem Diabetes Care (TNDM) | United States | $2.430B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.408B | 18.29 |
| TransMedics (TMDX) | United States | $2.145B | 67.98 |
| Elekta AB (EKTAY) | Sweden | $2.014B | 18.10 |
| Integra LifeSciences Holdings (IART) | United States | $1.708B | 8.92 |
| RxSight (RXST) | United States | $1.389B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.309B | 0.00 |
| Artivion (AORT) | United States | $1.197B | 79.31 |
| Pulse Biosciences (PLSE) | United States | $1.128B | 0.00 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| Paragon 28 (FNA) | United States | $0.860B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.736B | 12.52 |
| AxoGen (AXGN) | United States | $0.716B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.713B | 16.81 |
| IRadimed (IRMD) | United States | $0.687B | 37.13 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.663B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.661B | 34.77 |
| SiBone (SIBN) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.534B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.434B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.433B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.416B | 22.51 |
| Delcath Systems (DCTH) | United States | $0.363B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.353B | 0.00 |
| NeuroPace (NPCE) | United States | $0.333B | 0.00 |
| CVRx (CVRX) | United States | $0.313B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.216B | 0.00 |
| Inogen (INGN) | United States | $0.201B | 0.00 |
| Accuray (ARAY) | United States | $0.195B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.184B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| Nevro (NVRO) | United States | $0.149B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.130B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.111B | 11.93 |
| LENSAR (LNSR) | United States | $0.101B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.072B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.069B | 0.00 |
| 908 Devices (MASS) | United States | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Neuronetics (STIM) | United States | $0.044B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |